Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Nu.Q® Vet Cancer Test Product Brochure (UK & IRL)

Thursday, January 25, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Volition has announced the submission of a manuscript for its Nu.Q® Vet Cancer Test in cats, which is anticipated to unlock a $5 million milestone payment upon publication in a peer-reviewed journal. Additionally, the company has introduced the first automated version of this test in collaboration with Fujifilm Vet Systems, marking a significant step forward in veterinary cancer diagnostics.
Price reaction · baseline $22 (2024-01-24 close) · hit pre-market · 4 other VNRX headline(s) in the window, move may be shared
day 0 close
-5.5%
day 1
-2.7%
day 3 · peak
-8.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Submission of manuscript expected to unlock $5 million milestone payment.
  • First automated Nu.Q® Vet Cancer Test developed with Fujifilm Vet Systems.
  • Potential for significant advancements in veterinary cancer diagnostics.

Full Press Release Details

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is a diagnostic tool for detecting cancer in pets.

What milestone payment is associated with the Nu.Q® test?

The publication of the manuscript is expected to unlock a $5 million milestone payment.

Who collaborated with Volition on the automated test?

Volition collaborated with Fujifilm Vet Systems to develop the first automated Nu.Q® Vet Cancer Test.

Where is the Nu.Q® Vet Cancer Test brochure available?

The brochure is available for the UK and Ireland markets.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Nu.Q® veterinary cancer test Fujifilm Vet Systems milestone payment
Last updated: Jan 25, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk